These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17676393)

  • 21. A randomized, double-blind, one-week study comparing effects of a novel COX-2 inhibitor and naproxen on the gastric mucosa.
    Moberly JB; Harris SI; Riff DS; Dale JC; Breese T; McLaughlin P; Lawson J; Wan Y; Xu J; Truitt KE
    Dig Dis Sci; 2007 Feb; 52(2):442-50. PubMed ID: 17216336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A fixed-dose combination of naproxen and esomeprazole magnesium has comparable upper gastrointestinal tolerability to celecoxib in patients with osteoarthritis of the knee: results from two randomized, parallel-group, placebo-controlled trials.
    Cryer BL; Sostek MB; Fort JG; Svensson O; Hwang C; Hochberg MC
    Ann Med; 2011 Dec; 43(8):594-605. PubMed ID: 22017620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of gastroduodenal ulcer incidence in healthy Japanese subjects taking celecoxib or loxoprofen evaluated by endoscopy: a placebo-controlled, double-blind 2-week study.
    Sakamoto C; Kawai T; Nakamura S; Sugioka T; Tabira J
    Aliment Pharmacol Ther; 2013 Feb; 37(3):346-54. PubMed ID: 23216412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical trial: endoscopic evaluation of naproxen etemesil, a naproxen prodrug, vs. naproxen - a proof-of-concept, randomized, double-blind, active-comparator study.
    Goldstein JL; Jungwirthová A; David J; Spindel E; Bouchner L; Pešek F; Searle S; Skopek J; Grim J; Ulč I; Sewell KL
    Aliment Pharmacol Ther; 2010 Nov; 32(9):1091-101. PubMed ID: 20804454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alendronate and naproxen are synergistic for development of gastric ulcers.
    Graham DY; Malaty HM
    Arch Intern Med; 2001 Jan; 161(1):107-10. PubMed ID: 11146706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study.
    Rahme E; Nedjar H
    Rheumatology (Oxford); 2007 Mar; 46(3):435-8. PubMed ID: 17255138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aspirin Use in Secondary Cardiovascular Protection and the Development of Aspirin-Associated Erosions and Ulcers.
    Goldstein JL; Scheiman JM; Fort JG; Whellan DJ
    J Cardiovasc Pharmacol; 2016 Aug; 68(2):121-6. PubMed ID: 27002280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular risk associated with celecoxib or etoricoxib: a meta-analysis of randomized controlled trials which adopted comparison with placebo or naproxen.
    De Vecchis R; Baldi C; Di Biase G; Ariano C; Cioppa C; Giasi A; Valente L; Cantatrione S
    Minerva Cardioangiol; 2014 Dec; 62(6):437-48. PubMed ID: 25029569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy.
    Goldstein JL; Eisen GM; Lewis B; Gralnek IM; Aisenberg J; Bhadra P; Berger MF
    Aliment Pharmacol Ther; 2007 May; 25(10):1211-22. PubMed ID: 17451567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diclofenac/misoprostol compared with diclofenac in the treatment of osteoarthritis of the knee or hip: a randomized, placebo controlled trial. Arthrotec Osteoarthritis Study Group.
    Bocanegra TS; Weaver AL; Tindall EA; Sikes DH; Ball JA; Wallemark CB; Geis GS; Fort JG
    J Rheumatol; 1998 Aug; 25(8):1602-11. PubMed ID: 9712107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upper gastroduodenal ulceration in arthritis patients treated with celecoxib.
    Ashcroft DM; Chapman SR; Clark WK; Millson DS
    Ann Pharmacother; 2001; 35(7-8):829-34. PubMed ID: 11485128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies.
    Daniels S; Robbins J; West CR; Nemeth MA
    Clin Ther; 2009 Jun; 31(6):1192-208. PubMed ID: 19695387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Celecoxib is as efficacious as naproxen in the management of acute shoulder pain.
    Bertin P; Béhier JM; Noël E; Leroux JL
    J Int Med Res; 2003; 31(2):102-12. PubMed ID: 12760313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative efficacy and safety of celecoxib and naproxen in the treatment of osteoarthritis of the hip.
    Kivitz AJ; Moskowitz RW; Woods E; Hubbard RC; Verburg KM; Lefkowith JB; Geis GS
    J Int Med Res; 2001; 29(6):467-79. PubMed ID: 11803730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta-analysis: incidence of endoscopic gastric and duodenal ulcers in placebo arms of randomized placebo-controlled NSAID trials.
    Yuan YH; Wang C; Yuan Y; Hunt RH
    Aliment Pharmacol Ther; 2009 Aug; 30(3):197-209. PubMed ID: 19438429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Helicobacter pylori infection in gastroduodenal injury and gastric prostaglandin synthesis during long term/low dose aspirin therapy: a prospective placebo-controlled, double-blind randomized trial.
    Feldman M; Cryer B; Mallat D; Go MF
    Am J Gastroenterol; 2001 Jun; 96(6):1751-7. PubMed ID: 11419825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention with sucralfate gel of NSAID-induced gastroduodenal damage in arthritic patients.
    Miglioli M; Bianchi Porro G; Vaira D; Menegatti M; Brunetti G; Petrillo M; Ardizzone S; Frizziero L; Montrone F; Grandinetti G
    Am J Gastroenterol; 1996 Nov; 91(11):2367-71. PubMed ID: 8931419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endoscopic evaluation of low-dose aspirin-induced gastric and duodenal ulcers during prophylaxis with lansoprazole.
    Sakaki N; Ashida K; Mizokami Y; Chiba T; Matsui S; Kanto T; Uemura N; Hiramatsu N; Sugano K
    Hepatogastroenterology; 2013 Jun; 60(124):762-7. PubMed ID: 23478070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of outpatient physician claims for upper gastrointestinal symptoms among new users of celecoxib, ibuprofen, and naproxen in an insured population in the United States.
    Goldstein JL; Zhao SZ; Burke TA; Palmer R; von Allmen H; Henderson SC
    Am J Gastroenterol; 2003 Dec; 98(12):2627-34. PubMed ID: 14687808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary prevention of adverse gastroduodenal effects from short-term use of non-steroidal anti-inflammatory drugs by omeprazole 20 mg in healthy subjects: a randomized, double-blind, placebo-controlled study.
    Desai JC; Sanyal SM; Goo T; Benson AA; Bodian CA; Miller KM; Cohen LB; Aisenberg J
    Dig Dis Sci; 2008 Aug; 53(8):2059-65. PubMed ID: 18224442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.